Stoke Therapeutics Inc
NASDAQ:STOK 4:00:00 PM EDT
| Market Cap (Intraday) | 347.45M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $8.53 |
| 50-Day MA | $9.15 |
| 200-Day MA | $11.97 |
Stoke Therapeutics Inc Stock, NASDAQ:STOK
45 Wiggins Avenue, Bedford, Massachusetts 01730
United States of America
Phone: +1.781.430.8200
Number of Employees: 117
Description
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.